Background and aims: Genetic polymorphisms within the promoter of interferon-α receptor type-1 (IFNAR1) have been associated with the susceptibility to and the outcome of chronic hepatitis B virus (HBV) infection. However, the impact of these polymorphisms in the transcriptome of the HBV-associated hepatocellular carcinoma (HCC) remains largely unexplored. Methods: Using whole-genome and exome sequencing data from The Cancer Genome Atlas project, we characterized three single-nucleotide polymorphisms (SNPs: −568G/C, −408C/T, −3C/T) and one variable number tandem repeat [VNTR: −77(GT)n] within the IFNAR1 promoter sequence in 49 HCC patients. RNAseq data from 10 genotyped HCC samples were grouped according to their −77VNTR or −3SNP genotype t...
Implication for health policy/practice/research/medical education: Chronic hepatitis B infection dep...
Interferon alfa (IFN-alpha) therapy remains a mainstay of treatment in active hepatitis B. However, ...
Background & Aims: In patients with chronic HCV-1 infection, recent evidences indicate that det...
Background and aims<p>Genetic polymorphisms within the promoter of interferon-α receptor type-1 (IFN...
Background and aims<p>Genetic polymorphisms within the promoter of interferon-α receptor type-1 (IFN...
Background and aims<p>Genetic polymorphisms within the promoter of interferon-α receptor type-1 (IFN...
Background/Aims: Exposure to HBV leads to a distinct clinical course which is partially pertained to...
Background/Aims: We previously demonstrated that two linked single nucleotide polymorphisms (SNPs) a...
The type I interferon (IFN-α/β) receptor 1 (IFNAR1) mediates the potent antiviral and immuno-regulat...
The antiviral cascade triggered by interferon-γ (IFN-γ) represents a vital event for eradicating hep...
Hepatitis C Virus is one of the main reasons for chronic liver disease and hepatocellular carcinoma....
Abstract- Hepatitis C Virus is one of the main reasons for chronic liver disease and hepatocellular ...
[[abstract]]Interferon alfa (IFN-alpha) therapy remains a mainstay of treatment in active hepatitis ...
[[abstract]]Interferon alfa (IFN-alpha) therapy remains a mainstay of treatment in active hepatitis ...
Implication for health policy/practice/research/medical education: Chronic hepatitis B infection dep...
Implication for health policy/practice/research/medical education: Chronic hepatitis B infection dep...
Interferon alfa (IFN-alpha) therapy remains a mainstay of treatment in active hepatitis B. However, ...
Background & Aims: In patients with chronic HCV-1 infection, recent evidences indicate that det...
Background and aims<p>Genetic polymorphisms within the promoter of interferon-α receptor type-1 (IFN...
Background and aims<p>Genetic polymorphisms within the promoter of interferon-α receptor type-1 (IFN...
Background and aims<p>Genetic polymorphisms within the promoter of interferon-α receptor type-1 (IFN...
Background/Aims: Exposure to HBV leads to a distinct clinical course which is partially pertained to...
Background/Aims: We previously demonstrated that two linked single nucleotide polymorphisms (SNPs) a...
The type I interferon (IFN-α/β) receptor 1 (IFNAR1) mediates the potent antiviral and immuno-regulat...
The antiviral cascade triggered by interferon-γ (IFN-γ) represents a vital event for eradicating hep...
Hepatitis C Virus is one of the main reasons for chronic liver disease and hepatocellular carcinoma....
Abstract- Hepatitis C Virus is one of the main reasons for chronic liver disease and hepatocellular ...
[[abstract]]Interferon alfa (IFN-alpha) therapy remains a mainstay of treatment in active hepatitis ...
[[abstract]]Interferon alfa (IFN-alpha) therapy remains a mainstay of treatment in active hepatitis ...
Implication for health policy/practice/research/medical education: Chronic hepatitis B infection dep...
Implication for health policy/practice/research/medical education: Chronic hepatitis B infection dep...
Interferon alfa (IFN-alpha) therapy remains a mainstay of treatment in active hepatitis B. However, ...
Background & Aims: In patients with chronic HCV-1 infection, recent evidences indicate that det...